Edition:
United Kingdom

Celsion Corp (CLSN.OQ)

CLSN.OQ on NASDAQ Stock Exchange Capital Market

2.14USD
20 Mar 2019
Change (% chg)

$0.02 (+0.94%)
Prev Close
$2.12
Open
$2.10
Day's High
$2.20
Day's Low
$2.10
Volume
19,586
Avg. Vol
20,186
52-wk High
$3.47
52-wk Low
$1.36

Chart for

About

Celsion Corporation is an oncology drug development company. The Company's product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for treatment of primary liver cancer (the OPTIMA Study) and a Phase II clinical trial for treatment of recurrent chest wall... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $27.98
Shares Outstanding(Mil.): 8.35
Dividend: --
Yield (%): --

Financials

  CLSN.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -8.37 -- --
ROI: -78.33 8.89 13.82
ROE: -191.72 10.00 15.25

Earnings vs. Estimates